BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 861959)

  • 1. The carcinoid syndrome--a role for hemodialysis.
    Creagan ET; Tyce GM; Moertel CG
    Cancer Treat Rep; 1977; 61(1):107-8. PubMed ID: 861959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current views on carcinoid and the carcinoid syndrome].
    Ryss ES
    Klin Med (Mosk); 1971 Jan; 49(1):13-9. PubMed ID: 4396993
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of serotonin synthesis by para-chlorophenylalanine in patients with the carcinoid syndrome.
    Engelman K; Lovenberg W; Sjoerdsma A
    N Engl J Med; 1967 Nov; 277(21):1103-8. PubMed ID: 6054996
    [No Abstract]   [Full Text] [Related]  

  • 4. Carcinoid syndrome.
    Rose D
    Am J Nurs; 1980 Jan; 80(1):110-12. PubMed ID: 6153138
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of a possible physiologic interaction between ceruloplasmin and serotonin.
    Warner RR; Sternlieb I
    J Lab Clin Med; 1966 Jun; 67(6):934-6. PubMed ID: 5916141
    [No Abstract]   [Full Text] [Related]  

  • 6. The malignant carcinoid syndrome.
    Davis Z; Moertel CG; McIlrath DC
    Surg Gynecol Obstet; 1973 Oct; 137(4):637-44. PubMed ID: 4730072
    [No Abstract]   [Full Text] [Related]  

  • 7. Some newer aspects of the carcinoid syndrome.
    Eiband JM; Brown H; Gregory CH; Kahil ME
    Tex Med; 1966 Dec; 62(12):62-5. PubMed ID: 5980426
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome.
    Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA
    Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carcinoid syndrome: neuroendocrine and chemical considerations.
    Aleshire SL; Bradley CA; Parl FF
    Clin Lab Med; 1984 Dec; 4(4):803-15. PubMed ID: 6210171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bronchial carcinoid and carcinoid syndrome].
    Biriukov IuV; Bassalyk LS; Kulikov LS; Men'shikov VV; Efimov BI
    Sov Med; 1970 Dec; 33(12):39-43. PubMed ID: 5516942
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatic dearterialization in the treatment of carcinoid syndrome.
    Sjöblom SM; Höckerstedt K; Järvinen H
    Acta Chir Scand; 1987 Sep; 153(9):523-9. PubMed ID: 2447716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The carcinoid syndrome: methods of treatment and recent experience with hepatic artery ligation and infusion.
    Farndon JR
    Clin Oncol; 1977 Dec; 3(4):365-75. PubMed ID: 598064
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
    Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ileal carcinoid tumors. Predominant lesions of the left endocardium].
    Warter J; Batzenschlager A; Schirardin H; Grappe JM; Berthier G; Monath C
    Ann Med Interne (Paris); 1971 Oct; 122(10):967-74. PubMed ID: 5150731
    [No Abstract]   [Full Text] [Related]  

  • 15. [The syndrome of metastazing carcinoid. 3. Long-term follow up of 5-hydroxyindoleacetic acid excretion in the urine].
    Simon J; Láhn V; Opatrný K; Sova J; Sídlová A; Cerhová M; Hůla J; Virt S
    Cas Lek Cesk; 1968 Mar; 107(13):394-8. PubMed ID: 5664817
    [No Abstract]   [Full Text] [Related]  

  • 16. Discussion of the role of 5-hydroxyindoles in the carcinoid syndrome.
    Davis VE
    Adv Pharmacol (1962); 1968; 6(Pt B):143-5. PubMed ID: 5658312
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinguishing features of idiopathic flushing and carcinoid syndrome.
    Aldrich LB; Moattari AR; Vinik AI
    Arch Intern Med; 1988 Dec; 148(12):2614-8. PubMed ID: 2461688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carcinoid and carcinoid syndrome].
    Vrubel F; Martínek K
    Cesk Gastroenterol Vyz; 1970 Oct; 24(7):286-90. PubMed ID: 5480235
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laboratory findings in the carcinoid syndrome].
    Kähler HJ
    Dtsch Med Wochenschr; 1968 May; 93(19):959-61. PubMed ID: 5300909
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
    Jermendy G; Kónya A; Kárpáti P
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):130-6. PubMed ID: 2424713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.